You are browsing articles on the topic of Cardiac Surgery Archives - CardioExchange

Avatar of Larry Husten, PHD

FDA Grants Premarket Approval to AbioMed Heart Pump (24 Mar 2015)

News

The FDA said on Tuesday that it had approved Abiomed’s Impella 2.5 System. According to the company, it is is the first hemodynamic support device to gain FDA approval for use during high risk PCI procedures. The miniature blood pump is designed for temporary use in patients with severe symptomatic coronary artery disease and diminished (but…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

Encouraging 5-Year Results for TAVR (15 Mar 2015)

News

The publication five years ago of the two-part PARTNER trial brought a major change to the treatment of aortic valve replacement. The trial demonstrated that transcatheter aortic valve replacement (TAVR) was a reasonable treatment option, first for patients who were not surgical candidates and then for patients who were at high risk for surgery. One…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

First Good Look at TAVR in The Real World (10 Mar 2015)

News

Transcatheter aortic valve replacement (TAVR) is one of the most important advances in cardiovascular medicine in recent years. Although it is associated with significant risks, TAVR can offer some patients a less invasive alternative to traditional aortic valve replacement surgery.  Because of early concerns about potential overuse and misuse of TAVR, many observers have been eagerly…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Colleen

Has Lab Testing Become a Blood Sport for Cardiac Surgery Patients? (5 Mar 2015)

Voices

Colleen G. Koch, MD

A study of nearly 1900 cardiac surgery patients at Cleveland Clinic suggests blood is being drawn with surprisingly high frequency.

Avatar of Larry Husten, PHD

Hospitals, Like Vampires, Want Your Blood (2 Mar 2015)

News

Anyone who has been in the hospital, either as a patient or a healthcare provider, is keenly aware that hospitals perform a lot of tests. It has even been suggested that some of those tests may not be necessary. Now a new study published in the Annals of Thoracic Surgery sheds light on just how excessive…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

Aortic Valve Surgery for Nonagenarians (30 Oct 2014)

News

As people continue to live longer physicians are increasingly confronted with very elderly patients who have serious conditions that might benefit from surgery but who are at high risk for surgical complications. In a paper published in the Annals of Thoracic Surgery, doctors at the Mayo Clinic reviewed their experience with 59 patients age 90 or…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

No Difference in Survival Found for Different Aortic Valve Prostheses (30 Sep 2014)

News

A new study published in JAMA suggests that younger patients who need aortic valve replacement (AVR) may now be more eligible to receive bioprosthetic valves. Each year about 50,000 people in the U.S. undergo AVR surgery. Older patients generally receive bioprosthetic valves because these valves are less prone to clotting and bleeding complications. Surgeons are often…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

FDA Approves Second-Generation Heart Valve from Edwards Lifesciences (17 Jun 2014)

News

The next phase of the burgeoning and rapidly maturing transcatheter aortic valve replacement (TAVR) market has begun. Edwards Lifesciences announced on Monday afternoon that the FDA had approved its second-generation Sapien XT TAVR device  for the treatment of high-risk and inoperable patients suffering from severe symptomatic aortic stenosis (AS). The Sapien XT is the successor to the first-generation Sapien device,…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

Wide Range of Radiation Dose in Children Undergoing Cardiac Procedures (9 Jun 2014)

News

Children with heart disease are at increased risk for developing cancer later in life due to their exposure to radiation during imaging procedures. Since an ever-growing number of children with heart disease now reach adulthood, this may become an increasingly important public health issue. A new study published in Circulation offers some reassurance in finding…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Richard A. Lange, MD, MBA

Transcatheter Mitral Valve Programs: No Volume Data (4 Jun 2014)

Voices

Richard A. Lange, MD, MBA and L. David Hillis, MD

The Society for Cardiac Angiography and Interventions (SCAI), the American Association for Thoracic Surgery (AATS), the American College of Cardiology (ACC), and the Society of Thoracic Surgeons (STS) recently joined together to provide recommendations for institutions that are considering starting and/or maintaining a transcatheter mitral valve (MV) program. Unlike PCI, for which abundant data show…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.